2-151706832-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001164507.2(NEB):c.1152+49A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0163 in 1,345,140 control chromosomes in the GnomAD database, including 246 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 21 hom., cov: 32)
Exomes 𝑓: 0.017 ( 225 hom. )
Consequence
NEB
NM_001164507.2 intron
NM_001164507.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.370
Publications
2 publications found
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
- nemaline myopathy 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
- childhood-onset nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intermediate nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- typical nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- lethal multiple pterygium syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- severe congenital nemaline myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-151706832-T-C is Benign according to our data. Variant chr2-151706832-T-C is described in ClinVar as Benign. ClinVar VariationId is 257723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0124 (1894/152332) while in subpopulation SAS AF = 0.0209 (101/4832). AF 95% confidence interval is 0.0176. There are 21 homozygotes in GnomAd4. There are 918 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 21 AD,AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NEB | ENST00000397345.8 | c.1152+49A>G | intron_variant | Intron 13 of 181 | 5 | NM_001164508.2 | ENSP00000380505.3 | |||
| NEB | ENST00000427231.7 | c.1152+49A>G | intron_variant | Intron 13 of 181 | 5 | NM_001164507.2 | ENSP00000416578.2 | |||
| NEB | ENST00000489048.1 | n.51+49A>G | intron_variant | Intron 1 of 11 | 1 | |||||
| NEB | ENST00000409198.5 | c.1152+49A>G | intron_variant | Intron 13 of 149 | 5 | ENSP00000386259.1 |
Frequencies
GnomAD3 genomes AF: 0.0124 AC: 1889AN: 152214Hom.: 21 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1889
AN:
152214
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0164 AC: 2460AN: 150150 AF XY: 0.0174 show subpopulations
GnomAD2 exomes
AF:
AC:
2460
AN:
150150
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0167 AC: 19976AN: 1192808Hom.: 225 Cov.: 16 AF XY: 0.0172 AC XY: 10299AN XY: 597778 show subpopulations
GnomAD4 exome
AF:
AC:
19976
AN:
1192808
Hom.:
Cov.:
16
AF XY:
AC XY:
10299
AN XY:
597778
show subpopulations
African (AFR)
AF:
AC:
69
AN:
26662
American (AMR)
AF:
AC:
222
AN:
29738
Ashkenazi Jewish (ASJ)
AF:
AC:
1124
AN:
23474
East Asian (EAS)
AF:
AC:
0
AN:
35810
South Asian (SAS)
AF:
AC:
1935
AN:
71502
European-Finnish (FIN)
AF:
AC:
602
AN:
49648
Middle Eastern (MID)
AF:
AC:
124
AN:
5256
European-Non Finnish (NFE)
AF:
AC:
14919
AN:
899600
Other (OTH)
AF:
AC:
981
AN:
51118
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1024
2047
3071
4094
5118
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
554
1108
1662
2216
2770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0124 AC: 1894AN: 152332Hom.: 21 Cov.: 32 AF XY: 0.0123 AC XY: 918AN XY: 74492 show subpopulations
GnomAD4 genome
AF:
AC:
1894
AN:
152332
Hom.:
Cov.:
32
AF XY:
AC XY:
918
AN XY:
74492
show subpopulations
African (AFR)
AF:
AC:
119
AN:
41574
American (AMR)
AF:
AC:
164
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
149
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5194
South Asian (SAS)
AF:
AC:
101
AN:
4832
European-Finnish (FIN)
AF:
AC:
126
AN:
10622
Middle Eastern (MID)
AF:
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1173
AN:
68024
Other (OTH)
AF:
AC:
32
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
100
200
300
400
500
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
24
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.